Viral Hepatitis B&D Flashcards

1
Q

def of hepatitis B

A

infection with hepatitis B virus (HBV)

may follow an acute or chronic course

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is chronic HBV defined as

A

viraemia and hepatic inflammation >6months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

def of hepatitis D

A

defective virus
may only:
1 co-infect with HBV
2 superinfect carriers of HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what sort of virus is HBV

A

enveloped, partially DS DNA virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what sort of virus is HDV

A

SS RNA virus coated with HBsAg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

aetiology

A

HBV:

  • transmission by sexual contact, blood, vertical (mother to baby)
  • viral proteins are produced (HBcAg-core antigen, HBsAg-surface antigen, HBeAg)

antibody + cell-mediated immune responses to viral replication lead to liver inflammation + hepatocyte necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is HBeAG a marker of

A

increased infectivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

associations/risk factors

A

1 HBV

  • IV drug use
  • infants of HBeAg positive mothers
  • sexual contact with HBV carriers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

who is at risk of chronic HBV carriage

A

babies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

epi

A

HBV common in southeast asia, africa, uncommon in UK

350m worldwide infected with HBV, 1-2million deaths annually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

history

A
1 incubation period (time between infection exposure and symptoms) of 3-6months
2 prodromal symptoms
-malaise
-nausea, vomiting, diarrhoea
-RUQ pain
3 (occasionally) serum-sickness-type illness
-arthralgia
-maculopapular rash
4 dark urine + pale stools
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

examination

A
1 acute
-jaundice
-pyrexia
-tender hepatomegaly
-cervical lymphadenopathy
2 chronic
-may have no findings
-may be signs of CLD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

investigations

A

1 viral serology
2 PCR
3 bloods
-LFTs (very high AST + ALT, high bilirubin, high alkphos)
-clotting (prolonged PT in severe disease)
4 liver biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what does HBsAg positive, IgM anti-HBcAg indicate

A

acute HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what does HBsAg positive, IgG anti-HBcAg indicate

A

chronic HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what does anti-HBsAg positive, igG anti-HBcAg indicate

A

HBV cleared or immunity

17
Q

why is PCR used in investigating HBV?

A

detection of HBV DNA is the most sensitive measure of ongoing viral replication

18
Q

management by prevention

A

1 instrument sterilisation (IV drug users)
2 safe sex
3 passive+active immunisation (against HBV)

19
Q

why is immunisation only required against HBV

A

HBV immunisation protects against HDV too

as HDV co-infects with HBV or superinfects carriers of HBV

20
Q

management of acute HBV hepatitis

A

1 symptomatic control (antipyretics, antiemetics, cholestryamine for pruritis)
2 notify communicable disease control

21
Q

management of chronic HBV

A

1 antivirals (if indicated)

  • interferon-alpha, or
  • nucleos/tide analogues (adefovir, tenofovir)
22
Q

what are the indications for antivirals

A

1 HBeAg-positive or negative with chronic hepatitis

2 cirrhosis with HBV DNA by PCR

23
Q

what is inteferon alpha

A

a cytokine which enhances the bodies antiviral effects

24
Q

complications

A

1 fulminant hepatic failure (1%)
2 chronic HBV infection
3 cirrhosis

25
Q

what is fulminant hepatic failure

A

acute liver injury impairing functioning and causing hepatic encephalopathy in a patient without previous liver disease

26
Q

prognosis

A

10% become chronic, and of these, 20-30% will develop cirrhosis
high serum transaminases and low HBV DNA indicate a good response to interferon